DNTH
Dianthus Therapeutics, Inc.
Stock
$88.21−0.11 (−0.12%)Close Oct 2, 2026
Balance sheet
| Line | Q2 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and short-term investments | $108M | $50M | $22M | $131M | $75M | $177M | $149M | $146M | $143M | $51M | $4.5M |
| Current assets | $898M | $409M | $281M | $177M | $82M | $181M | $152M | $150M | $145M | $53M | — |
| Total assets | $1.2B | $531M | $374M | $179M | $83M | $190M | $162M | $162M | $157M | $54M | — |
| Current liabilities | $34M | $31M | $18M | $9.6M | $8.2M | $11M | $11M | $14M | $10M | $4.1M | — |
| Total liabilities | $41M | $38M | $22M | $11M | $9.5M | $17M | $18M | $20M | $12M | $4.1M | — |
| Shareholders' equity | $1.2B | $493M | $352M | $169M | −$44M | $173M | $144M | $141M | $146M | −$42M | −$8.9M |
| Shares outstanding | 55.9M | 44.5M | 32.1M | 29.3M | 60.6M | 58.8M | 48.6M | 39.3M | 33.5M | — | — |
| Current ratio | 26.10 | 13.32 | 15.22 | 18.42 | 9.97 | 16.63 | 13.26 | 10.62 | 13.95 | 12.68 | — |